PDCD1 and neoplasm: Improved control of tumor and survival with the combination of anti–PD-1 and APR-246 was also seen in an MC38 colorectal carcinoma model (Supplemental Figure 1B) and TC1, an HPV tumor model (Supplemental Figure 1C).